← All Targets

dihydrofolate reductase

3 drugs

Oncology

Market Leader

AXTLE

AVYXA HOLDINGS

approved indications

Approved Drugs

Companies

Indications

Therapeutic Areas

Top Drugs

PEMETREXED FOR INJECTION

Dr. Reddy's

2 indications

Unlock Full Target Intelligence PRO

✓ Competitive landscape by company (3 companies)

✓ All 3 approved drugs

✓ Therapeutic area breakdown

✓ Full indication list (2 indications)

✓ Patent cliff analysis

✓ Clinical trials pipeline

Upgrade to Pro

Starting at $99/mo

Unlock with Pro →

Drugs by Company

AVYXA HOLDINGS 1 drug

EAGLE PHARMS 1 drug

Dr. Reddy's 1 drug

By Therapeutic Area

Oncology 3 drugs

Drugs by Company PRO

AVYXA HOLDINGS 1 drug

AXTLE

EAGLE PHARMS 1 drug

PEMFEXY

Dr. Reddy's 1 drug

PEMETREXED FOR INJECTION

By Therapeutic Area

Oncology 3 drugs

AXTLE, PEMFEXY, PEMETREXED FOR INJECTION

Indications Treated

Non-Small Cell Lung CancerMalignant Pleural Mesothelioma

All Drugs Targeting dihydrofolate reductase

Drug	Company	Approved	Indications	Therapeutic Area
AXTLE	AVYXA HOLDINGS	2024	2	Oncology
PEMFEXY	EAGLE PHARMS	2020	2	Oncology
PEMETREXED FOR INJECTION	Dr. Reddy's	-	2	Oncology